Report on the methacholine bronchial provocation test protocol: An updated statement of Korean Academy of Asthma, Allergy and Clinical Immunology
10.4168/aard.2023.11.2.56
- Author:
Kyoung-Hee SOHN
1
;
Hwan Soo KIM
;
Byung-Keun KIM
;
Joo-Hee KIM
;
Sang Min LEE
;
Jae-Hyun LEE
;
Sung-Il WOO
;
Cheol Hong KIM
;
Jae Won JUNG
;
Sae-Hoon KIM
Author Information
1. Division of Pulmonology and Allergy, Department of Internal Medicine, KyungHee University Medical Center, Seoul, Korea
- Publication Type:REVIEW
- From:Allergy, Asthma & Respiratory Disease
2023;11(2):56-62
- CountryRepublic of Korea
- Language:English
-
Abstract:
The Korean Academy of Asthma, Allergy, and Clinical Immunology task force report aims to provide new protocols for methacholine challenge test (MCT). Although new devices have different delivery system compared to old ones, previous protocols are still used, which cannot guarantee adequate diagnoses of asthma. Another important issue is the recent recommendation in European Respiratory Society (ERS) technical standard guideline to use a delivered methacholine dose that causes a 20% decrease in forced expiratory volume in 1 second (FEV1) (PD 20). Although the previous protocol based on the methacholine concentration causing a 20% decrease in FEV1 (PC 20) has been used globally, several studies have reported that PD 20 is more reliable and applicable for new protocols of MCT. Indeed, a tidal breathing inhalation protocol using a breath-actuated or continuous nebulizer is recommended. Herein, we recommend 3 protocols for the MCT using new devices and provide a brief summary of the change in strategy based on the updated ERS guideline.
